Tag: biologics

Researchers link to facilitate cheaper biologics

by Selina McKee | Apr 6, 2021 | News | 0

The parties intend to develop more cost-effective ways of producing biologic medicines

Takeda acquires PvP Biologics

by Anna Smith | Feb 26, 2020 | News | 0

The acquisition follows the conclusion of a Phase I proof-of-mechanism study of investigational medicine TAK-062.

Takeda to evaluate Crescendo Biologics’ Humabodies

by Anna Smith | Jan 4, 2019 | News | 0

Crescendo Biologics has announced that Takeda is planning to evaluate the application of its recently licensed Humabodies, for the development of novel CAR-T therapeutics.

Celltrion calls for wider use of biologics in RA

by Selina McKee | Sep 6, 2018 | News | 0

Celltrion Healthcare is calling on the NHS to consider lowering the threshold for starting biologics in patients with rheumatoid arthritis (RA), and to put in place measures to boost patient access to such treatment.

Samsung Bioepis ventures into novel R&D with Takeda deal

by Selina McKee | Aug 22, 2017 | News | 0

Samsung Bioepis is joining forces with Takeda Pharmaceutical to jointly fund and co-develop multiple novel biologic therapies in unmet disease areas, taking its first step towards developing new pharmaceuticals.